Codify — Article

Second Chance Reauthorization Act of 2025 extends grants, adds substance‑use and housing services

Updates the Second Chance Act and related grant authorities to authorize programs through 2030 and explicitly add substance‑use disorder treatment and reentry housing to reentry demonstration activities.

The Brief

The bill reauthorizes components of the Second Chance Act of 2007 and related grant programs by changing multiple statutory expiration dates to "2026 through 2030." It also amends the state and local reentry demonstration project statute to permit grantees to provide substance use disorder treatment (including peer recovery services, case management, overdose education, and access to overdose reversal medication) and to provide reentry housing services.

This is a narrow, programmatic bill: it does not create a new federal program or specify appropriation levels. Instead, it extends authorization windows for existing grant streams and broadens allowable activities for reentry demonstration grants, signaling a policy emphasis on health and housing interventions as part of reentry work.

For practitioners, the bill mainly preserves grant eligibility through 2030 and expands what grantees can propose and fund under those awards.

At a Glance

What It Does

Amends the Omnibus Crime Control and Safe Streets Act and the Second Chance Act to add two allowable activities to state and local reentry demonstration projects—substance use disorder treatment (with peer recovery, case management, overdose education and reversal medication) and reentry housing services—and replaces multiple earlier expiration dates with the period "2026 through 2030."

Who It Affects

The changes directly affect Office of Justice Programs/OVC grant programs, state and local governments that run reentry demonstration projects, community‑based reentry and mentoring organizations, correctional education providers, and behavioral‑health providers that partner on reentry grants.

Why It Matters

By authorizing these programs through 2030 and explicitly adding health and housing services to allowable activities, the bill makes it administratively clearer that reentry grants can fund integrated treatment and housing strategies—potentially shifting grant solicitations and applicant priorities—while leaving funding levels and appropriations decisions to future action.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The core change in this bill is surgical: it updates statutory language to keep a set of reentry and correctional education grant authorities alive through 2030 and clarifies what activities reentry demonstration projects may support. For the demonstration projects that let states and localities pilot reentry strategies, the bill adds two specific buckets of activity—substance use disorder treatment (enumerating peer recovery services, case management, overdose education, and access to overdose reversal medications) and reentry housing services—so applicants can propose and use funds for those services without statutory uncertainty.

On the authorization side, the bill swaps out a cluster of expiring year ranges and replaces them with a uniform "2026 through 2030" window for multiple provisions in both the Omnibus Crime Control and Safe Streets Act and the Second Chance Act (the changes affect statutory citations including 34 U.S.C. 10631, 10595a, 10261, 60511, 60521, and 60531). Those edits keep existing grant programs and evaluation authorities available to solicit and award grants for the next authorization window, but they do not alter formulas, award ceilings, or create new appropriation authority.Practically, grantees and states that run reentry programs should expect solicitations and program guidance to reflect the newly explicit authority to fund SUD treatment and housing as part of reentry demonstrations.

Program administrators will need to translate the statutory additions into procurement, clinician partnerships, naloxone training and distribution protocols, housing placement strategies, and performance metrics. Federal administrators will have to decide whether to adjust priorities, model solicitations, or issue cross‑program guidance to account for the broader allowable activities.Finally, because the bill does not specify appropriations nor add compliance details or definitions (for example, it does not define "reentry housing services" or set standards for peer recovery services), much of the implementation work—scope, eligibility, reporting, and oversight—will fall to the agencies that run these grants and to grantees adapting proposals to the expanded activities.

The Five Things You Need to Know

1

The bill amends 34 U.S.C. 10631(b) (state and local reentry demonstration projects) to add two new allowable activities: treating substance use disorders (explicitly including peer recovery services, case management, overdose education, and access to overdose reversal medications) and providing reentry housing services.

2

It replaces multiple prior authorization windows (various 2019–2023 and 2019–2023 lists) with a uniform authorization period of "2026 through 2030" for selected Second Chance Act and Omnibus Crime Control and Safe Streets Act grant authorities.

3

Specific statutory provisions updated to the 2026–2030 window include: 34 U.S.C. 10595a(a) (family‑based substance abuse grants), 34 U.S.C. 10261(a)(28) (prison/jail/juvenile education evaluation grants), 34 U.S.C. 60511(f) (career training demonstration grants), 34 U.S.C. 60521(f)(1) (offender reentry substance abuse/criminal justice collaboration), 34 U.S.C. 60531(f) (community‑based mentoring/transitional services), and 34 U.S.C. 10631(o)(1).

4

The bill is limited in scope: it changes authorized activities and authorization periods but does not amend appropriations language, funding formulas, or add new funding amounts or mechanisms.

5

Because the bill explicitly authorizes overdose reversal medication access within reentry demonstrations, grantees will need to address operational issues such as training, storage/dispensing rules, and potential coordination with state medical or pharmacy boards when deploying those services.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Names the Act the "Second Chance Reauthorization Act of 2025." This is a drafting convention with no operational effect, but it signals the bill's narrow focus on reauthorization and continuity for Second Chance Act‑related programs.

Section 2(a) — Amendment to 34 U.S.C. 10631(b)

Adds SUD treatment and reentry housing to allowable demonstration activities

This amendment inserts two new numbered activities into the statutory list of what state and local reentry demonstration projects may do. The first enumerates treating substance use disorders and specifies peer recovery services, case management, overdose education, and access to overdose reversal medications; the second adds reentry housing services. The mechanics are straightforward: applicants can now include those services in grant proposals and expense lines without having to rely on broader interpretations. The statute does not define any of these terms, so program offices will need to provide implementing guidance if they want uniform standards across grantees.

Section 2(a) — Amendment to 34 U.S.C. 10631(o)(1)

Extends authorization period for reentry demonstration grants

This change replaces an earlier expiration date range with the period "2026 through 2030," effectively reauthorizing the reentry demonstration authority for that timeframe. Legally, reauthorizing preserves the Secretary's authority to make grants under that section during those years; it does not itself appropriate funds. The practical implication is that federal solicitations and multi‑year project planning can proceed with the assurance that the statutory authority remains in effect through 2030.

2 more sections
Section 2(b) — Amendment to 34 U.S.C. 10595a(a)

Reauthorizes family‑based substance abuse treatment grants

This subsection swaps the earlier 2019–2023 authorization window in the Omnibus Crime Control and Safe Streets Act for "2026 through 2030," continuing the authorization for grants that fund family‑based substance abuse interventions tied to criminal justice involvement. The provision is procedural—keeps the grant authority active—but again leaves appropriations and precise program priorities to separate budgetary and administrative actions.

Section 2(c–f)

Uniform extension across education, career training, collaboration, and mentoring grants

Subsections (c) through (f) apply the same replacement of expired year ranges with "2026 through 2030" across a set of grant authorities: correctional education evaluation (34 U.S.C. 10261(a)(28)), careers training demonstration grants (34 U.S.C. 60511(f)), offender reentry substance abuse and criminal justice collaboration (34 U.S.C. 60521(f)(1)), and community‑based mentoring/transitional services to nonprofits (34 U.S.C. 60531(f)). The practical effect is to keep these separate but related funding authorities synchronized for the next authorization window, simplifying program continuity and cross‑program partnerships.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Criminal Justice across all five countries.

Explore Criminal Justice in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • People returning from incarceration who need substance use disorder treatment and stable housing — the statute now explicitly permits these services within reentry demonstration projects, increasing the likelihood they will be funded in grant proposals.
  • Community‑based reentry organizations and nonprofits that provide peer recovery, case management, and housing navigation — they can be included as allowable service providers in demonstration grants without statutory ambiguity.
  • State and local corrections and reentry program managers — the uniform extension through 2030 preserves eligibility to apply for and receive federal grants that support pilot programs and scaling of evidence‑based reentry practices.
  • Correctional education and career training providers — reauthorization of evaluation and demonstration authorities maintains the legal basis for education and workforce development grants tied to reentry.

Who Bears the Cost

  • Office of Justice Programs/OVC and federal grant administrators — they will carry the implementation and oversight burden of integrating health and housing activities into grant solicitations, monitoring, and reporting.
  • Grantees and nonprofit partners — organizations that expand into SUD treatment or housing may face new administrative, clinical, and liability costs (staffing, training, storage and distribution protocols for medications like naloxone, data reporting).
  • State and local governments and correctional agencies — operational coordination (health partnerships, housing placement systems) may require additional staffing or contractual arrangements not covered by existing awards unless additional appropriations follow.
  • Medicaid and state behavioral health systems — if reentry programs bridge to Medicaid‑funded services or supplant existing state supports, coordination demands and potential cost‑shifts may arise.

Key Issues

The Core Tension

The central tension is between broadening what reentry grants can pay for—explicitly adding health and housing interventions that evidence suggests reduce recidivism—and failing to provide funding, definitions, or implementation guardrails; the bill empowers grantees on paper but shifts the real cost and complexity of delivery, oversight, and cross‑sector coordination onto agencies, providers, and state/local systems without creating a clear federal funding or regulatory framework.

The bill expands statutory authority for reentry demonstrations to include SUD treatment and reentry housing, but it stops short of funding those expansions or setting operational standards. That mismatch creates a practical implementation question: agencies and grantees will need to translate broad authorizations into procurement rules, clinical standards for peer recovery services, protocols for distributing overdose reversal medication, and definitions for what counts as "reentry housing services." Without guidance, programs could vary widely across jurisdictions and create inconsistent service quality and reporting.

There are also legal and administrative frictions the statute does not address. Deploying overdose reversal medication in a reentry setting raises state medical, pharmacy, and liability considerations that grant administrators will need to reconcile with federal grant conditions.

Similarly, providing housing as a grant‑funded activity collides with local housing supply constraints, landlord selection and payment mechanisms, fair housing obligations, and coordination with public housing authorities—operational complexities that the statute does not resolve. Finally, reauthorizing multiple authorities through 2030 preserves the legal framework for grants but creates no guarantee of appropriated dollars; sustained impact depends on future budget choices and interagency coordination (for example, with HHS/Medicaid and HUD) that the bill leaves to other processes.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.